Peptide-based vaccines for tuberculosis

W Gong, C Pan, P Cheng, J Wang, G Zhao… - Frontiers in …, 2022 - frontiersin.org
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. As a
result of the coronavirus disease 2019 (COVID-19) pandemic, the global TB mortality rate in …

A History of the Development of Brucella Vaccines

ED Avila-Calderón, A Lopez-Merino… - BioMed research …, 2013 - Wiley Online Library
Brucellosis is a worldwide zoonosis affecting animal and human health. In the last several
decades, much research has been performed to develop safer Brucella vaccines to control …

Towards a Brucella vaccine for humans

SD Perkins, SJ Smither, HS Atkins - FEMS microbiology reviews, 2010 - academic.oup.com
There is currently no licensed vaccine for brucellosis in humans. Available animal vaccines
may cause disease and are considered unsuitable for use in humans. However, the …

The advances in brucellosis vaccines

H Hou, X Liu, Q Peng - Vaccine, 2019 - Elsevier
Brucellosis is a worldwide zoonosis affecting animal and human health. Till now, there is no
effective vaccine licensed for brucellosis in humans. Although M5, H38 and 45/20 vaccines …

Progress in Brucella vaccine development

X Yang, JA Skyberg, L Cao, B Clapp, T Thornburg… - Frontiers in biology, 2013 - Springer
Brucella spp. are zoonotic, facultative intracellular pathogens, which cause animal and
human disease. Animal disease results in abortion of fetuses; in humans, it manifests flu-like …

[HTML][HTML] Prophylactic vaccine delivery systems against epidemic infectious diseases

C Pan, H Yue, L Zhu, G Ma, H Wang - Advanced drug delivery reviews, 2021 - Elsevier
Prophylactic vaccines have evolved from traditional whole-cell vaccines to safer subunit
vaccines. However, subunit vaccines still face problems, such as poor immunogenicity and …

Therapeutic and prophylactic applications of alphavirus vectors

GJ Atkins, MN Fleeton, BJ Sheahan - Expert reviews in molecular …, 2008 - cambridge.org
Alphavirus vectors are high-level, transient expression vectors for therapeutic and
prophylactic use. These positive-stranded RNA vectors, derived from Semliki Forest virus …

Oral immunization of mice with recombinant Lactococcus lactis expressing Cu, Zn superoxide dismutase of Brucella abortus triggers protective immunity

D Sáez, P Fernández, A Rivera, E Andrews, A Oñate - Vaccine, 2012 - Elsevier
Brucella infections mainly occur through mucosal surfaces. Thus, the development of
mucosal administered vaccines could be instrumental for the control of brucellosis. Here, we …

Meta-analysis and advancement of brucellosis vaccinology

TF Carvalho, JPA Haddad, TA Paixao, RL Santos - PloS one, 2016 - journals.plos.org
Background/Objectives In spite of all the research effort for developing new vaccines against
brucellosis, it remains unclear whether these new vaccine technologies will in fact become …

[HTML][HTML] Development of new generation of vaccines for Brucella abortus

A Gheibi, H Khanahmad, K Kashfi, M Sarmadi… - Heliyon, 2018 - cell.com
Brucella abortus is a Gram-negative facultative and intracellular bacteria, it causes bovine
brucellosis, a zoonotic disease that is responsible for considerable economic loss to owners …